CLINICAL_TRIALS
trial_result
· 2009-09-28
Clinical Trial Update: A Study To Assess The Safety And Efficacy Of SU11248 In Patients With Gastrointestinal Stromal Tumor(GIST) [Phase 3]
Summary
Phase 3 clinical trial evaluating the safety and efficacy of SU11248 in patients with gastrointestinal stromal tumor; results were posted in 2009.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Gastrointestinal Stromal Tumor | Phase 3 | Status: COMPLETED | Results posted: 2009-09-28